
Bacteria [375]


Dorian Obino
Born and raised in the south of France, I moved to Paris to study at the Magistère Européen de Génétique (Université Paris VII, now Université Paris Cité) where I specialized in immuno-genetics and cell biology. […]

Emanuela Pisani
Collection of Cyanobacteria

Inhibition of peptidoglycan assembly complexes
Ivo Gomperts Boneca

Maia Delage Toriel
Medical Center of the Institut Pasteur
Dr Maia Delage-Toriel is is dermatologist at Pasteur Institute Medical Center. She Works mainly about Verneuil, Hidradenitis suppurativa, inflammation disease, microbiote and biofilm. Dr Nassif and Dr Delage are currently also starting a metabolomic […]

Aude Nassif
Medical Center of the Institut Pasteur
Dr Aude Nassif performed her MD, residency and chief residency in Dermatology in France, then worked on Atopic Dermatitis with Pr Hanifin in Portland, Oregon, USA. Back in Paris, she was in charge of Atopic […]

Sequana: a set of flexible NGS pipelines
Thomas Cokelaer

Iradj Sobhani
Dr. Sobhani Iradj is the director of Liver and Gastro-intestinal department in Henri Mondor Hospital Creteil-APHP. He is also Director of Research team (EA7375) in University Paris Est Creteil (UPEC) on Eraly detection of […]

Louis-Antoine Barel
Group: Carbohydrates and Bioconjugates

Johan Cornil
Group: Carbohydrates and Bioconjugates

Maimouna Djamila N’Gadjaga
Djamila joined our group for her Master’s degree internship wanting to study more the cellular aspect of host-pathogen interaction. She studied the consequences of inhibiting Chlamydia trachomatis’ Type III Secretion System on the development of the […]

John Rohde
Dynamics of Host-Pathogen Interactions

Bacteriophage gene expression by RNA-Seq
Laurent Debarbieux

PTR OmNega: A multi-disciplinary investigation of the Negativicutes: atypical Firmicutes with LPS-outer membranes that inhabit the human gut
Simonetta Gribaldo

Samuel Alvarez Arguesdas
Integrated Mycobacterial Pathogenomics
Samuel Álvarez-Arguedas is doing his PhD in Biochemistry and Molecular Biology at the University of Zaragoza, Spain, under the supervision of Prof. Carlos Martín, focusing on the study and characterization of the new tuberculosis vaccine, […]
